pioglitazone has been researched along with Alveolar Proteinoses, Pulmonary in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dupin, C | 1 |
| Hurtado, M | 1 |
| Cazes, A | 1 |
| Taille, C | 1 |
| Debray, MP | 1 |
| Guenée, C | 1 |
| Tabeze, L | 1 |
| Crestani, B | 1 |
| Borie, R | 1 |
| Vis, DC | 1 |
| Kelly, MM | 1 |
| De Heuvel, E | 1 |
| MacEachern, PR | 1 |
| Sallese, A | 1 |
| Suzuki, T | 1 |
| McCarthy, C | 1 |
| Bridges, J | 1 |
| Filuta, A | 1 |
| Arumugam, P | 1 |
| Shima, K | 1 |
| Ma, Y | 1 |
| Wessendarp, M | 1 |
| Black, D | 1 |
| Chalk, C | 1 |
| Carey, B | 1 |
| Trapnell, BC | 1 |
3 other studies available for pioglitazone and Alveolar Proteinoses, Pulmonary
| Article | Year |
|---|---|
Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience.
Topics: Humans; Pioglitazone; Pulmonary Alveolar Proteinosis | 2020 |
Reduction in Alveolar Macrophage Size in Refractory Autoimmune Pulmonary Alveolar Proteinosis After Treatment With Pioglitazone.
Topics: Autoimmune Diseases; Bronchoalveolar Lavage Fluid; Fibrosis; Granulocyte-Macrophage Colony-Stimulati | 2020 |
Targeting cholesterol homeostasis in lung diseases.
Topics: Animals; Cell Differentiation; Cholesterol; Disease Models, Animal; Granulocyte-Macrophage Colony-St | 2017 |